Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 346

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 346
---
 applicable to the convertible
security.

The September 2024 PIPE Common Warrants will
be exercisable beginning six months after the issuance date (the “Initial Exercisability Date”) and expiring on the third
anniversary of the Initial Exercisability Date. The September 2024 PIPE Common Warrants require “buy-in” payments to be made
by us for failure to deliver any shares of Common Stock issuable upon exercise.

If at the time of exercise of the September 2024
PIPE Common Warrants, there is no effective registration statement registering the shares of the Common Stock underlying the Common September
2024 PIPE Warrants, such warrants may be exercised on a cashless basis pursuant to their terms.

If we issue options, convertible securities,
warrants, shares, or similar securities to holders of Common Stock, each holder of September 2024 PIPE Common Warrants has the right
to acquire the same as if the holder had exercised its September 2024 PIPE Common Warrants. The holders of September 2024 PIPE Common
Warrants are entitled to receive any dividends paid or distributions made to our holders of Common Stock on an “as if converted”
basis.

The September 2024 PIPE Common Warrants prohibit
us from entering into specified fundamental transactions unless the successor entity assumes all of our obligations under the September
2024 PIPE Common Warrants under a written agreement before the transaction is completed. Upon specified corporate events, a holder of
September 2024 PIPE Common Warrants will thereafter have the right to receive upon an exercise such shares, securities, cash, assets
or any other property whatsoever which the holder would have been entitled to receive upon the happening of the applicable corporate
event had the September 2024 PIPE Common Warrants been exercised immediately prior to the applicable corporate event. When there is a
transaction involving specified changes of control, a holder of September 2024 PIPE Common Warrants can request the Company to exchange
the then unexercised portion of their September 2024 PIPE Common Warrants for consideration equal to the Black-Scholes value thereof,
which shall be settled, at the option of the Company in either (i) the form of rights convertible into the consideration receivable by
holders of the underlying shares of common stock, based upon the value of the shares of the successor entity over a specified period
or (ii) cash in an amount equal to the Black-Scholes value.

<div align='center'>F-21</div>

The Company’s September